LEUKEMOGENESIS and PANCYTOPENIA
See full prescribing information for complete boxed warning.
- TRADE NAMES: Citosulfan; Leukosulfan; Mablin; Misulban; Myleran (GSK)
- INDICATIONS: Chronic myelogenous leukemia, bone marrow disorders
- CLASS: Alkylating agent
- HALF-LIFE: 3.4 hours (after first dose)
- CLINICALLY IMPORTANT, POTENTIALLY HAZARDOUS INTERACTIONS WITH:
Acetaminophen, Aldesleukin, Itraconazole, Metronidazole, Voriconazole
- See adverse reactions attributed to class:
Please login to view the rest of this drug profile.
Page last updated 08/02/2023
